Eosinophil activation in the cerebrospinal fluid of children with shunt obstruction

Pediatric Neurosurgery

Volumn 46, Issue 4, 2010, Pages 255-258

  Heidemann, Sabrina M ^a   Fiore, Michael ^a   Sood, Sandeep ^a   Ham, Steven ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eosinophil cationic protein; Eosinophil derived neurotoxin; Eosinophils; Shunt obstruction

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X;

ADOLESCENT; ADULT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CATHETER OCCLUSION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CHILD; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FOLLOW UP; HUMAN; HYDROCEPHALUS; INFECTION; INTENSIVE CARE UNIT; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT FAILURE;

EID: 78650039743     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320130     Document Type: Article

References (15)

1. Kossovsky N, Snow RB: Clinical-pathological analysis of failed central nervous system fluid shunts. J Biomed Mater Res 1989; 23(A1 suppl):73-86.
2. Sekhar LN, Moossy J, Guthkelch AN: Malfunctioning ventriculoperitoneal shunts. Clinical and pathological features. J Neurosurg 1982; 56: 411-416.
3. Del Bigio MR: Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery 1998; 42: 319-325, discussion 325-316.
4. Snow RB, Kossovsky N: Hypersensitivity reaction associated with sterile ventriculoperitoneal shunt malfunction. Surg Neurol 1989; 31: 209-214.
5. Tung H, Raffel C, McComb JG: Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts. J Neurosurg 1991; 75: 541-544.
6. Rothenberg ME: Eosinophilia. N Engl J Med 1998; 338: 1592-1600.
7. Tanaka T, Ikeuchi S, Yoshino K, Isoshima A, Abe T: A case of cerebrospinal fluid eosinophilia associated with shunt malfunction. Pediatr Neurosurg 1999; 30: 6-10.
8. Tangsinmankong N, Nelson RP, Jr., Good RA: Glucocorticosteroid treatment for cerebrospinal fluid eosinophilia in a patient with ventriculoperitonial shunt. Ann Allergy Asthma Immunol 1999; 83: 341-342.
9. Wiersbitzky SK, Ahrens N, Becker T, Panzig B, Abel J, Stenger RD: The diagnostic importance of eosinophil granulocytes in the CSF of children with ventricular-peritoneal shunt systems. Acta Neurol Scand 1998; 97: 201-203.
10. McClinton D, Carraccio C, Englander R: Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J 2001; 20: 593-597.
11. Fulkerson DH, Boaz JC: Cerebrospinal fluid eosinophilia in children with ventricular shunts. J Neurosurg Pediatr 2008; 1: 288-295.
12. Giembycz MA, Lindsay MA: Pharmacology of the eosinophil. Pharmacol Rev 1999; 51: 213-340.
13. Fredens K, Dahl R, Venge P: The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 1982; 70: 361-366. (Pubitemid 13233284)
14. Ellis MJ, Kazina CJ, Del Bigio MR, McDonald PJ: Treatment of recurrent ventriculoperitoneal shunt failure associated with persistent cerebrospinal fluid eosinophilia and latex allergy by use of an 'extracted' shunt. J Neurosurg Pediatr 2008; 1: 237-239.
15. Bell RS, Vo AH, Cooper PB, Schmitt CL, Rosner MK: Eosinophilic meningitis after implantation of a rifampin and minocyclineimpregnated ventriculostomy catheter in a child. Case report. J Neurosurg 2006; 104(1 suppl):50-54.